Brian Lian is listed as a director on 5 SEC Form D filings by 1 issuer between Aug 2019 and Jul 2024: SEELOS THERAPEUTICS, INC. (New York, NY — biotechnology — 2019–2024; $4M reported sold to 13 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Brian Lian and found 5 differences: Bankruptcy case: SEELOS THERAPEUTICS, INC; Bankruptcy case: Dalesandro Contactors, Inc; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.